BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18208851)

  • 21. Medical physics aspects of particle therapy.
    Jäkel O
    Radiat Prot Dosimetry; 2009 Nov; 137(1-2):156-66. PubMed ID: 19828718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerators for heavy-charged-particle radiation therapy.
    Coutrakon GB
    Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):49-54. PubMed ID: 17668952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mechanism-based approach to predict the relative biological effectiveness of protons and carbon ions in radiation therapy.
    Frese MC; Yu VK; Stewart RD; Carlson DJ
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):442-50. PubMed ID: 22099045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ion beam radiobiology and cancer: time to update ourselves.
    Fokas E; Kraft G; An H; Engenhart-Cabillic R
    Biochim Biophys Acta; 2009 Dec; 1796(2):216-29. PubMed ID: 19682551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling in vivo relative biological effectiveness in particle therapy for clinically relevant endpoints.
    Lühr A; von Neubeck C; Helmbrecht S; Baumann M; Enghardt W; Krause M
    Acta Oncol; 2017 Nov; 56(11):1392-1398. PubMed ID: 28849720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of radiation quality on the risks of second malignancies.
    Manem VS; Kohandel M; Hodgson DC; Sharpe MB; Sivaloganathan S
    Int J Radiat Biol; 2015 Mar; 91(3):209-17. PubMed ID: 25356906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Particle beam radiation therapy in prostate cancer: is there an advantage?
    Rossi CJ; Slater JD; Reyes-Molyneux N; Yonemoto LT; Archambeau JO; Coutrakon G; Slater JM
    Semin Radiat Oncol; 1998 Apr; 8(2):115-23. PubMed ID: 9516592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose or 'LET' painting--What is optimal in particle therapy of hypoxic tumors?
    Malinen E; Søvik Å
    Acta Oncol; 2015; 54(9):1614-22. PubMed ID: 26198655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients.
    Suit H; DeLaney T; Goldberg S; Paganetti H; Clasie B; Gerweck L; Niemierko A; Hall E; Flanz J; Hallman J; Trofimov A
    Radiother Oncol; 2010 Apr; 95(1):3-22. PubMed ID: 20185186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Charged particles in radiation oncology.
    Durante M; Loeffler JS
    Nat Rev Clin Oncol; 2010 Jan; 7(1):37-43. PubMed ID: 19949433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro RBE-LET dependence for multiple particle types.
    Sørensen BS; Overgaard J; Bassler N
    Acta Oncol; 2011 Aug; 50(6):757-62. PubMed ID: 21767171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative biological effectiveness of carbon ions for tumor control, acute skin damage and late radiation-induced fibrosis in a mouse model.
    Sørensen BS; Horsman MR; Alsner J; Overgaard J; Durante M; Scholz M; Friedrich T; Bassler N
    Acta Oncol; 2015; 54(9):1623-30. PubMed ID: 26271798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning.
    Krämer M; Weyrather WK; Scholz M
    Technol Cancer Res Treat; 2003 Oct; 2(5):427-36. PubMed ID: 14529307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A challenge for high-precision radiation therapy: the case for photons.
    Gahbauer RA
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():121-2. PubMed ID: 10394419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractionation effects in particle radiotherapy: implications for hypo-fractionation regimes.
    Carabe-Fernandez A; Dale RG; Hopewell JW; Jones B; Paganetti H
    Phys Med Biol; 2010 Oct; 55(19):5685-700. PubMed ID: 20826903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Charged particle therapy: the physics of interaction.
    Lomax AJ
    Cancer J; 2009; 15(4):285-91. PubMed ID: 19672144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption characteristics of protons and photons in tissue.
    Dicello JF
    Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):25-9. PubMed ID: 17668948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relative biological effectiveness for carbon and oxygen ion beams using the raster-scanning technique in hepatocellular carcinoma cell lines.
    Habermehl D; Ilicic K; Dehne S; Rieken S; Orschiedt L; Brons S; Haberer T; Weber KJ; Debus J; Combs SE
    PLoS One; 2014; 9(12):e113591. PubMed ID: 25460352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.